LUCELLON

Serial Number 88103996
Registration 5877790
700

Registration Progress

Application Filed
Sep 4, 2018
Under Examination
Approved for Publication
Jul 23, 2019
Published for Opposition
Jul 23, 2019
Registered
Oct 8, 2019

Trademark Image

LUCELLON

Basic Information

Serial Number
88103996
Registration Number
5877790
Filing Date
September 4, 2018
Registration Date
October 8, 2019
Published for Opposition
July 23, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 8, 2019
Registration
Registered
Classes
005

Rights Holder

Eutilex Co., Ltd.

03
Address
Suite #408,
58, Gasan digital 1-ro, Geumcheon-gu,
Seoul 08591
KR

Ownership History

Eutilex Co., Ltd.

Original Applicant
03
Seoul KR

Eutilex Co., Ltd.

Owner at Publication
03
Seoul KR

Eutilex Co., Ltd.

Original Registrant
03
Seoul KR

Legal Representation

Attorney
Jong H Park

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description Documents
Oct 8, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Nov 23, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 23, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 23, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 23, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 23, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 19, 2021 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Aug 19, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 19, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 19, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 19, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 19, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 21, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 21, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 21, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 21, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 21, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 8, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 23, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 23, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 3, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 19, 2019 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Jun 14, 2019 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Jun 10, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 23, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 23, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 22, 2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Dec 14, 2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Dec 14, 2018 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Dec 14, 2018 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 10, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 10, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 7, 2018 ALIE A ASSIGNED TO LIE Loading...
Dec 3, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 16, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 16, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 16, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 15, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 7, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer cells; Cells for medical or clinical use; Pharmaceutical preparations for activating cellular function; Biological preparations for the treatment of immune system related disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for tumor treatment; Vaccines; Pharmaceutical preparations for the treatment of cancers with T cells

Classification

International Classes
005